{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:17:55Z","timestamp":1784938675932,"version":"3.55.0"},"reference-count":51,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0120","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:54:11Z","timestamp":1728561251000},"source":"Crossref","is-referenced-by-count":2,"title":["Monogenic kidney diseases in adults with chronic kidney disease"],"prefix":"10.3238","author":[{"given":"Julian","family":"Eble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla T.","family":"Schulthei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"10.3238\/arztebl.m2024.0120_ref1","doi-asserted-by":"crossref","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al.: KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024; 105: S117\u2013S314","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"10.3238\/arztebl.m2024.0120_ref2","doi-asserted-by":"crossref","unstructured":"Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A: The prevalence of renal failure\u2014results from the German Health Interview and Examination Survey for adults, 2008\u20132011 (DEGS1). Dtsch Arztebl Int 2016; 113: 85\u201391","DOI":"10.3238\/arztebl.2016.0085"},{"key":"10.3238\/arztebl.m2024.0120_ref3","doi-asserted-by":"crossref","unstructured":"Groopman EE, Marasa M, Cameron-Christie S, et al.: Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 2019; 380: 142\u201351","DOI":"10.1056\/NEJMc1903250"},{"key":"10.3238\/arztebl.m2024.0120_ref4","doi-asserted-by":"crossref","unstructured":"Connaughton DM, Hildebrandt F: Personalized medicine in chronic kidney disease by detection of monogenic mutations. Nephrol Dial Transplant 2020; 35: 390\u20137","DOI":"10.1093\/ndt\/gfz028"},{"key":"10.3238\/arztebl.m2024.0120_ref5","doi-asserted-by":"crossref","unstructured":"Torra R, Furlano M, Ortiz A, Ars E: Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin Kidney J 2021; 14: 1879\u201385","DOI":"10.1093\/ckj\/sfab056"},{"key":"10.3238\/arztebl.m2024.0120_ref6","doi-asserted-by":"crossref","unstructured":"Knoers N, Antignac C, Bergmann C, et al.: Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice. Nephrol Dial Transplant 2022; 37: 239\u201354","DOI":"10.1093\/ndt\/gfab218"},{"key":"10.3238\/arztebl.m2024.0120_ref7","doi-asserted-by":"crossref","unstructured":"Eckardt KU, Coresh J, Devuyst O, et al.: Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013; 382: 158\u201369","DOI":"10.1016\/S0140-6736(13)60439-0"},{"key":"10.3238\/arztebl.m2024.0120_ref8","doi-asserted-by":"crossref","unstructured":"Stokman MF, Renkema KY, Giles RH, Schaefer F, Knoers NV, van Eerde AM: The expanding phenotypic spectra of kidney diseases: insights from genetic studies. Nat Rev Nephrol 2016; 12: 472\u201383","DOI":"10.1038\/nrneph.2016.87"},{"key":"10.3238\/arztebl.m2024.0120_ref9","doi-asserted-by":"crossref","unstructured":"Al-Hamed MH, Hussein MH, Shah Y, et al.: Exome sequencing unravels genetic variants associated with chronic kidney disease in Saudi Arabian patients. Hum Mutat 2022; 43: e24\u2013e37","DOI":"10.1002\/humu.24480"},{"key":"10.3238\/arztebl.m2024.0120_ref10","doi-asserted-by":"crossref","unstructured":"Bogyo K, Vena N, May H, et al.: Incorporating genetics services into adult kidney disease care. Am J Med Genet C Semin Med Genet 2022; 190: 289\u2013301","DOI":"10.1002\/ajmg.c.32004"},{"key":"10.3238\/arztebl.m2024.0120_ref11","doi-asserted-by":"crossref","unstructured":"Domingo-Gallego A, Pybus M, Bullich G, et al.: Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol Dial Transplant 2022; 37: 687\u201396","DOI":"10.1093\/ndt\/gfab019"},{"key":"10.3238\/arztebl.m2024.0120_ref12","doi-asserted-by":"crossref","unstructured":"Doreille A, Lombardi Y, Dancer M, et al.: Exome-first strategy in adult patients with CKD: a cohort study. Kidney Int Rep 2022; 8: 596\u2013605","DOI":"10.1016\/j.ekir.2022.12.007"},{"key":"10.3238\/arztebl.m2024.0120_ref13","doi-asserted-by":"crossref","unstructured":"Elhassan EAE, Murray SL, Connaughton DM, et al.: The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project. J Nephrol 2022; 35: 1655\u201365","DOI":"10.1007\/s40620-021-01236-2"},{"key":"10.3238\/arztebl.m2024.0120_ref14","doi-asserted-by":"crossref","unstructured":"Jayasinghe K, Stark Z, Kerr PG, et al.: Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med 2021; 23: 183\u201391","DOI":"10.1038\/s41436-020-00963-4"},{"key":"10.3238\/arztebl.m2024.0120_ref15","doi-asserted-by":"crossref","unstructured":"Lata S, Marasa M, Li Y, et al.: Whole-exome sequencing in adults with chronic kidney disease: a pilot study. Ann Intern Med 2018; 168: 100\u20139","DOI":"10.7326\/M17-1319"},{"key":"10.3238\/arztebl.m2024.0120_ref16","doi-asserted-by":"crossref","unstructured":"Schrezenmeier E, Kremerskothen E, Halleck F, et al.: The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation. Genet Med 2021; 23: 1219\u201324","DOI":"10.1038\/s41436-021-01127-8"},{"key":"10.3238\/arztebl.m2024.0120_ref17","doi-asserted-by":"crossref","unstructured":"Vaisitti T, Sorbini M, Callegari M, et al.: Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. J Nephrol 2021; 34: 1767\u201381","DOI":"10.1007\/s40620-020-00898-8"},{"key":"10.3238\/arztebl.m2024.0120_ref18","doi-asserted-by":"crossref","unstructured":"Wang Z, Xu H, Xiang T, et al.: An accessible insight into genetic findings for transplantation recipients with suspected genetic kidney disease. NPJ Genom Med 2021; 6: 57","DOI":"10.1038\/s41525-021-00219-3"},{"key":"10.3238\/arztebl.m2024.0120_ref19","doi-asserted-by":"crossref","unstructured":"Wilson PC, Love-Gregory L, Corliss M, McNulty S, Heusel JW, Gaut JP: Beyond panel-based testing: exome analysis increases sensitivity for diagnosis of genetic kidney disease. Kidney360 2020; 1: 772\u201380","DOI":"10.34067\/KID.0001342020"},{"key":"10.3238\/arztebl.m2024.0120_ref20","unstructured":"KDIGO Conference Participants: Genetics in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 2022; 101: 1126\u201341"},{"key":"10.3238\/arztebl.m2024.0120_ref21","doi-asserted-by":"crossref","unstructured":"Aron AW, Dahl NK, Besse W: A practical guide to genetic testing for kidney disorders of unknown etiology. Kidney360 2022; 3: 1640\u201351","DOI":"10.34067\/KID.0007552021"},{"key":"10.3238\/arztebl.m2024.0120_ref22","doi-asserted-by":"crossref","unstructured":"Hildebrandt F: Genetic kidney diseases. Lancet 2010; 375: 1287\u201395","DOI":"10.1016\/S0140-6736(10)60236-X"},{"key":"10.3238\/arztebl.m2024.0120_ref23","doi-asserted-by":"crossref","unstructured":"Cirillo L, Becherucci F: Genetic testing in nephrology: show your pedigree! Kidney360 2022; 3: 2148\u201352","DOI":"10.34067\/KID.0002732022"},{"key":"10.3238\/arztebl.m2024.0120_ref24","doi-asserted-by":"crossref","unstructured":"Devarajan P, Chertow GM, Susztak K, et al.: Emerging role of clinical genetics in CKD. Kidney Med 2022; 4: 100435","DOI":"10.1016\/j.xkme.2022.100435"},{"key":"10.3238\/arztebl.m2024.0120_ref25","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, et al.: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405\u201324","DOI":"10.1038\/gim.2015.30"},{"key":"10.3238\/arztebl.m2024.0120_ref26","doi-asserted-by":"crossref","unstructured":"Schultheiss UT, Hermle T: Genetische Diagnostik bei Nierenerkrankungen im Erwachsenenalter. Nephrologie 2023; 18: 153\u20139","DOI":"10.1007\/s11560-023-00646-6"},{"key":"10.3238\/arztebl.m2024.0120_ref27","doi-asserted-by":"crossref","unstructured":"Dahl NK, Bloom MS, Chebib FT, et al.: The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease. J Am Soc Nephrol 2023; 34: 2039\u201350","DOI":"10.1681\/ASN.0000000000000249"},{"key":"10.3238\/arztebl.m2024.0120_ref28","doi-asserted-by":"crossref","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE: Polycystic kidney disease. Nat Rev Dis Primers 2018; 4: 50","DOI":"10.1038\/s41572-018-0047-y"},{"key":"10.3238\/arztebl.m2024.0120_ref29","doi-asserted-by":"crossref","unstructured":"Chebib FT, Perrone RD, Chapman AB, et al.: A practical guide for treatment of rapidly progressive ADPKD with tolvaptan. J Am Soc Nephrol 2018; 29: 2458\u201370","DOI":"10.1681\/ASN.2018060590"},{"key":"10.3238\/arztebl.m2024.0120_ref30","doi-asserted-by":"crossref","unstructured":"Groopman EE, Povysil G, Goldstein DB, Gharavi AG: Rare genetic causes of complex kidney and urological diseases. Nat Rev Nephrol 2020; 16: 641\u201356","DOI":"10.1038\/s41581-020-0325-2"},{"key":"10.3238\/arztebl.m2024.0120_ref31","doi-asserted-by":"crossref","unstructured":"Owens DK, Davidson KW, Krist AH, et al.: Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. Jama 2019; 322: 652\u201365","DOI":"10.1001\/jama.2019.10987"},{"key":"10.3238\/arztebl.m2024.0120_ref32","doi-asserted-by":"crossref","unstructured":"Becherucci F, Landini S, Palazzo V, et al.: A clinical workflow for cost-saving high-rate diagnosis of genetic kidney diseases. J Am Soc Nephrol 2023; 34: 706\u201320","DOI":"10.1681\/ASN.0000000000000076"},{"key":"10.3238\/arztebl.m2024.0120_ref33","doi-asserted-by":"crossref","unstructured":"Lavu S, Vaughan LE, Senum SR, et al.: The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. JCI Insight 2020; 5: e138724","DOI":"10.1172\/jci.insight.138724"},{"key":"10.3238\/arztebl.m2024.0120_ref34","doi-asserted-by":"crossref","unstructured":"Rossetti S, Consugar MB, Chapman AB, et al.: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143\u201360","DOI":"10.1681\/ASN.2006121387"},{"key":"10.3238\/arztebl.m2024.0120_ref35","doi-asserted-by":"crossref","unstructured":"Hateboer N, v Dijk MA, Bogdanova N, et al.: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999; 353: 103\u20137","DOI":"10.1016\/S0140-6736(98)03495-3"},{"key":"10.3238\/arztebl.m2024.0120_ref36","doi-asserted-by":"crossref","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE: Polycystic kidney disease. Nat Rev Dis Primers 2018; 4: 50","DOI":"10.1038\/s41572-018-0047-y"},{"key":"10.3238\/arztebl.m2024.0120_ref37","doi-asserted-by":"crossref","unstructured":"Luciano RL, Dahl NK: Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 2014; 29: 247\u201354","DOI":"10.1093\/ndt\/gft437"},{"key":"10.3238\/arztebl.m2024.0120_ref38","doi-asserted-by":"crossref","unstructured":"Mallawaarachchi AC, Lundie B, Hort Y, et al.: Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing. Eur J Hum Genet 2021; 29: 760\u201370","DOI":"10.1038\/s41431-020-00796-4"},{"key":"10.3238\/arztebl.m2024.0120_ref39","doi-asserted-by":"crossref","unstructured":"Nozu K, Nakanishi K, Abe Y, et al.: A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 2019; 23: 158\u201368","DOI":"10.1007\/s10157-018-1629-4"},{"key":"10.3238\/arztebl.m2024.0120_ref40","doi-asserted-by":"crossref","unstructured":"Lee JM, Nozu K, Choi DE, Kang HG, Ha IS, Cheong HI: Features of autosomal recessive Alport syndrome: a systematic review. J Clin Med 2019; 8: 178","DOI":"10.3390\/jcm8020178"},{"key":"10.3238\/arztebl.m2024.0120_ref41","doi-asserted-by":"crossref","unstructured":"Matthaiou A, Poulli T, Deltas C: Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review. Clin Kidney J 2020; 13: 1025\u201336","DOI":"10.1093\/ckj\/sfz176"},{"key":"10.3238\/arztebl.m2024.0120_ref42","doi-asserted-by":"crossref","unstructured":"Jais JP, Knebelmann B, Giatras I, et al.: X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000; 11: 649\u201357","DOI":"10.1681\/ASN.V114649"},{"key":"10.3238\/arztebl.m2024.0120_ref43","doi-asserted-by":"crossref","unstructured":"Jais JP, Knebelmann B, Giatras I, et al.: X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 2003; 14: 2603\u201310","DOI":"10.1097\/01.ASN.0000090034.71205.74"},{"key":"10.3238\/arztebl.m2024.0120_ref44","doi-asserted-by":"crossref","unstructured":"Malone AF, Phelan PJ, Hall G, et al.: Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 2014; 86: 1253\u20139","DOI":"10.1038\/ki.2014.305"},{"key":"10.3238\/arztebl.m2024.0120_ref45","doi-asserted-by":"crossref","unstructured":"Olinger E, Hofmann P, Kidd K, et al.: Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int 2020; 98: 717\u201331","DOI":"10.1016\/j.kint.2020.04.038"},{"key":"10.3238\/arztebl.m2024.0120_ref46","doi-asserted-by":"crossref","unstructured":"\u017divn\u00e1 M, Kidd KO, Bare\u0161ov\u00e1 V, Hůlkov\u00e1 H, Kmoch S, Bleyer AJ, Sr.: Autosomal dominant tubulointerstitial kidney disease: a review. Am J Med Genet C Semin Med Genet 2022; 190: 309\u201324","DOI":"10.1002\/ajmg.c.32008"},{"key":"10.3238\/arztebl.m2024.0120_ref47","doi-asserted-by":"crossref","unstructured":"Mabillard H, Sayer JA, Olinger E: Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrol Dial Transplant 2023; 38: 271\u201382","DOI":"10.1093\/ndt\/gfab268"},{"key":"10.3238\/arztebl.m2024.0120_ref48","doi-asserted-by":"crossref","unstructured":"Gast C, Marinaki A, Arenas-Hernandez M, et al.: Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol 2018; 19: 301","DOI":"10.1186\/s12882-018-1107-y"},{"key":"10.3238\/arztebl.m2024.0120_ref49","doi-asserted-by":"crossref","unstructured":"Kołbuc M, Le\u00dfmeier L, Salamon-Słowińska D, et al.: Hypomagnesemia is underestimated in children with HNF1B mutations. Pediatr Nephrol 2020; 35: 1877\u201386","DOI":"10.1007\/s00467-020-04576-6"},{"key":"10.3238\/arztebl.m2024.0120_ref50","doi-asserted-by":"crossref","unstructured":"\u017divn\u00e1 M, Kidd K, Zaidan M, et al.: An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. Kidney Int 2020; 98: 1589\u2013604","DOI":"10.1016\/j.kint.2020.06.041"},{"key":"10.3238\/arztebl.m2024.0120_ref51","doi-asserted-by":"crossref","unstructured":"Econimo L, Schaeffer C, Zeni L, et al.: Autosomal dominant tubulointerstitial kidney disease: an emerging cause of genetic CKD. Kidney Int Rep 2022; 7: 2332\u201344","DOI":"10.1016\/j.ekir.2022.08.012"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T11:31:05Z","timestamp":1732879865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":51,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0120","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}